Nurse Practitioner · Rochester, NY
NPI
1194836767
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
601 Elmwood Ave
Rochester, NY, 14642
Phone (585) 275-8503
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,515
146 services
Medicare patients, 2024
67
Average age 64
Drug cost, 2024
$7.5M
1,363 prescriptions
Company payments, 2025
$795
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Debra J Guntrum was code 99215 (office e&m - established), 50 times for 39 patients. In total Debra J Guntrum billed 146 services in 8 codes, and Medicare paid $7,515.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 50 | 39 | $80.51 | $4,026 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 31 | 27 | $10.68 | $331 |
| 99214 Office E&M - Established | Facility | 20 | 19 | $56.43 | $1,129 |
By year: 2022 $6,204 for 103 services; 2023 $5,459 for 95 services; 2024 $7,515 for 146 services.
Medicare prescription drug claims, 2024
In 2024, the drug Debra J Guntrum prescribed most often to Medicare patients was Mycophenolate Mofetil, with 219 prescriptions and refills. In total Debra J Guntrum wrote 1,363 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mycophenolate Mofetil Generic | 219 | 319 | 50 | $31K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 197 | 200 | 13 | $1.5M |
| Gabapentin Generic | 157 | 240 | 40 | $2,723 |
| Prednisone Generic | 110 | 181 | 28 | $532 |
| Pyridostigmine Bromide Generic | 47 | 86 | 19 | $3,083 |
| Exondys-51 Eteplirsen | 46 | 46 | Under 11 | $2.1M |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 46 | 46 | Under 11 | $284K |
| Emflaza Deflazacort | 37 | 37 | Under 11 | $425K |
| Deflazacort Generic | 36 | 44 | Under 11 | $209K |
| Evrysdi Risdiplam | 34 | 34 | Under 11 | $900K |
| Amitriptyline Hcl Generic | 34 | 68 | Under 11 | $493 |
| Baclofen Generic | 28 | 32 | Under 11 | $610 |
| Pregabalin Generic | 24 | 28 | Under 11 | $513 |
| Mexiletine Hcl Generic | 22 | 34 | Under 11 | $3,107 |
| Solu-Cortef Hydrocortisone Sodium Succ/Pf | 21 | 21 | Under 11 | $689 |
Brand drugs: 487 claims; generic drugs: 876 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Debra J Guntrum $795 ($795 in general payments such as food, travel and fees) from 3 companies. The largest payer was UCB, Inc. with $560.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.